Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Materials (Basel) ; 14(24)2021 Dec 17.
Article in English | MEDLINE | ID: mdl-34947415

ABSTRACT

This article discusses the fracture modelling accuracy of strain-driven ductile fracture models when introducing damage of high strength sheet steel. Numerical modelling of well-known fracture mechanical tests was conducted using a failure and damage model to control damage and fracture evolution. A thorough validation of the simulation results was conducted against results from laboratory testing. Such validations show that the damage and failure model is suited for modelling of material failure and fracture evolution of specimens without damage. However, pre-damaged specimens show less correlation as the damage and failure model over-predicts the displacement at crack initiation with an average of 28%. Consequently, the results in this article show the need for an extension of the damage and failure model that accounts for the fracture mechanisms at the crack tip. Such extension would aid in the improvement of fracture mechanical testing procedures and the modelling of high strength sheet metal manufacturing, as several sheet manufacturing processes are defined by material fracture.

2.
Fundam Clin Pharmacol ; 27(5): 465-70, 2013 Oct.
Article in English | MEDLINE | ID: mdl-22607657

ABSTRACT

Regulation of angiogenesis involves tight cell-to-cell and cell-to-extracellular-matrix interactions. Various reports demonstrate that the Wnt signaling pathways participate in this regulation. Using a three-dimensional aortic ring culture combined with an ex vivo retroviral infection approach, we evaluated the effects of two Wnt growth factors, Wnt-1 and Wnt-4, on the formation and growth of new capillaries. Our results show that Wnt-1 had no effect, whereas Wnt-4 was a potent inhibitor of capillary outgrowth in vitro.


Subject(s)
Angiogenesis Inhibitors/metabolism , Aorta, Abdominal/metabolism , Capillaries/metabolism , Endothelium, Vascular/metabolism , Extracellular Matrix/metabolism , Neovascularization, Physiologic , Wnt4 Protein/metabolism , 3T3 Cells , Angiogenesis Inhibitors/genetics , Animals , Aorta, Abdominal/cytology , Capillaries/cytology , Coculture Techniques , Endothelium, Vascular/cytology , Glycoproteins/genetics , Glycoproteins/metabolism , Imaging, Three-Dimensional , Immunohistochemistry , Intracellular Signaling Peptides and Proteins , Male , Mice , Rats , Rats, Sprague-Dawley , Recombinant Proteins/metabolism , Tissue Culture Techniques , Wnt1 Protein/genetics , Wnt1 Protein/metabolism , Wnt4 Protein/genetics
3.
Int J Hypertens ; 20102010.
Article in English | MEDLINE | ID: mdl-20948562

ABSTRACT

Renin-producing cells have been the object of intense research efforts for the past fifty years within the field of hypertension. Two decades ago, research focused on the concept and characterization of the intrarenal renin-angiotensin system. Early morphological studies led to the concept of the juxtaglomerular apparatus, a minute organ that links tubulovascular structures and function at the single nephron level. The kidney, thus, appears as a highly "topological organ" in which anatomy and function are intimately linked. This point is reflected by a concurrent and constant development of functional and structural approaches. After summarizing our current knowledge about renin cells and their distribution along the renal vascular tree, particularly along glomerular afferent arterioles, we reviewed a variety of imaging techniques that permit a fine characterization of renin synthesis, storage, and release at the single-arteriolar, -cell, or -granule level. Powerful tools such as multiphoton microscopy and transgenesis bear the promises of future developments of the field.

5.
J Hazard Mater ; 170(1): 345-50, 2009 Oct 15.
Article in English | MEDLINE | ID: mdl-19473758

ABSTRACT

In this paper the mechanical properties of magnesium potassium phosphate cements used for the Stabilization/Solidification (S/S) of galvanic wastes were investigated. Surrogate wastes (metal nitrate dissolutions) were employed containing Cd, Cr(III), Cu, Ni, Pb or Zn at a concentration of 25 g dm(-3) and different water-to-solid (W/S) ratios (0.3, 0.4, 0.5 and 0.6 dm(3)kg(-1)) have been employed. Cements were prepared by mixing hard burned magnesia of about 70% purity with potassium dihydrogen phosphate. Compressive strength and tensile strength of specimens were determined. In addition the volume of permeable voids was measured. It was found that when comparing pastes that the volume of permeable voids increases and mechanical strength decreases with the increase of water-to-solid ratio (W/S). Nevertheless pastes with the same material proportions containing different metals show different mechanical strength values. The hydration products were analyzed by XRD. With the increase of water content not previously reported hydration compound was detected: bobierrite.


Subject(s)
Conservation of Natural Resources/methods , Magnesium Compounds/chemistry , Manufactured Materials/standards , Metals, Heavy/chemistry , Phosphates/chemistry , Water/chemistry , Compressive Strength , Industrial Waste/prevention & control , Refuse Disposal , Tensile Strength
6.
Am J Physiol Renal Physiol ; 295(4): F1142-8, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18701627

ABSTRACT

Schwann cells (Sc), associated axons, and nearby vascular endothelium constitute a functional trilogy of major importance during the development and regrowth of peripheral vascular nerves. The goal of the present study is to provide a technique of triple fluorescence confocal imaging of these cell types along renal preglomerular vessels. We took advantage of a protein S100B/EGFP transgenic mouse to visualize Sc. The endothelium was labeled with an intravenous injection of fluorescently tagged lectin, and after tissue processing, adrenergic nerves were revealed with an antibody against the marker protein synaptophysin. As a validation step, we found that EGFP-positive perivascular cells with prominent cell bodies and extensive, multidirectional cell processes were protein S100B positive. They were identified as Sc and indirectly assumed to be unmyelinated Sc. By contrast, we found strong EGFP expression in proximal epithelial cells and in the epithelium lining thin limbs of Henle. This epithelial fluorescence was not associated with immunoreactive protein S100B and thus corresponded to ectopic EGFP expressions in this mouse strain. Sc were organized in bundles or as a meshwork surrounding the preglomerular vasculature from arcuate arteries to afferent arterioles. No Sc were detected in the medulla. Although most Sc were closely apposed to adrenergic varicosities, many varicosities were not associated with detectable Sc processes. The present technique, and the capacity of confocal microscopy to yield three-dimensional imaging, allow the study of the microtopology of Sc and related sympathetic axons in the renal perivascular interstitium.


Subject(s)
Kidney Glomerulus/innervation , Microscopy, Confocal/methods , Microscopy, Fluorescence/methods , Schwann Cells/cytology , Sympathetic Nervous System/cytology , Adrenergic Fibers/physiology , Animals , Biomarkers , Green Fluorescent Proteins/genetics , Imaging, Three-Dimensional , Immunohistochemistry , Male , Mice , Mice, Transgenic , Nerve Growth Factors/genetics , Plant Lectins , S100 Calcium Binding Protein beta Subunit , S100 Proteins/genetics , Schwann Cells/physiology , Sympathetic Nervous System/physiology
7.
Am J Physiol Regul Integr Comp Physiol ; 295(5): R1512-8, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18768771

ABSTRACT

Cardiac vessel density (beta-actin immunolabeling) and angiogenic capacity of coronary artery explants (culture in collagen gel) was determined in hypertrophied heart obtained by exercise training (10 wk) or ANG II infusion for 10 days. A group of rats received ANG II the last 10 days of training. The heart weight index was similarly elevated after exercise, and ANG II-hypertension compared with controls (3.16 +/- 0.09 and 3.11 +/- 0.11 vs. 2.68 +/- 0.08 mg/g, respectively), whereas tail cuff pressure (TCP) increased only in sedentary rats infused with ANG II. Vessel density was increased by 36% in trained rats and reduced by 30% in ANG II-infused rats. The number of sprouts generated by coronary rings was reduced by 50% in ANG II-infused rats and increased by 50% in exercise trained rats compared with controls (35 +/- 4 and 113 +/- 5 vs. 71 +/- 1 sprouts per ring, respectively). Exercise-training partly prevented the hypertensive effect of ANG II (TCP of 141 +/- 5 mmHg), whereas heart weight index (3.66 +/- 0.06 mg/g body wt) was not lowered. Myocardial vessel density was normalized, and sprouting from coronary rings increased by 50% in trained rats infused with ANG II compared with sedentary normotensive rats. Cardiac VEGF (Western blot analysis) was higher in hypertensive rats and not affected by exercise. Facing a similar increase in cardiac mass, intense training, but not ANG II hypertension, is accompanied by an increase in vascular density of the heart. The effect of training is unlikely related to changes in resting VEGF and may represent enhanced angiogenic capacity of the coronary vascular bed.


Subject(s)
Angiotensin II , Heart/physiology , Hypertension/pathology , Neovascularization, Physiologic/physiology , Physical Conditioning, Animal/physiology , Vasoconstrictor Agents , Animals , Blood Pressure/physiology , Blotting, Western , Capillaries/physiology , Carotid Arteries/pathology , Coronary Vessels/growth & development , Coronary Vessels/pathology , Echocardiography , Heart Rate/physiology , Heart Ventricles/physiopathology , Hypertension/chemically induced , Male , Myocardium/pathology , Rats , Rats, Sprague-Dawley , Vascular Endothelial Growth Factor A/biosynthesis , Vascular Endothelial Growth Factor A/genetics
8.
Am J Physiol Renal Physiol ; 295(4): F1222-9, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18715942

ABSTRACT

Clinical studies suggest a strong link between tissue calcification and pressure hyperpulsatility in end stage renal disease patients. Using a Wistar rat model of arterial elastocalcinosis and hyperpulsatility [vitamin D and nicotine (VDN) treatment], we evaluated the relative importance of tissue calcification and hyperpulsatility in the etiology of renal failure. VDN rats showed significant increases in aortic wall calcium content (50 times; 992+/-171 vs. control 19+/-1 micromol/g dry wt) and pulse pressure (1.5 times; 61+/-4 vs. control 40+/-2 mmHg). Significant renal calcification (16 times; 124+/-27 vs. control 8.1+/-0.7 micromol/g dry wt) occurred mainly within the media of the preglomerular vasculature and in the areas of interstitial fibrosis in VDN. Extensive renal damages (5 times; 26+/-5% of collapsed-atrophic or sclerotic glomeruli, or glomerular cysts vs. control 5.2+/-0.3%; 28 times; 61+/-12% areas of focal, cortical areas exhibiting interstitial fibrosis per section vs. control 2.2+/-0.6%) were observed histologically. The glomerular filtration rate significantly decreased (880+/-40 vs. control 1,058+/-44 microl.min(-1).g kidney wt(-1)). Albuminuria increased six times (1.6+/-0.4 vs. control 0.27+/-0.04 mg/24 h). There were significant linear relationships between albuminuria and pulse pressure (r2=0.408; n=24) or renal calcium content (r2=0.328; n=24; P<0.05) and between glomerular filtration rate and pulse pressure (r2=0.168; n=27). To our knowledge, this study provides the first evidence of links between both 1) hyperpulsatility and renal dysfunction, and 2) renal calcification and renal dysfunction. Given the increasing frequency of end-stage renal disease, this model could prove useful for preclinical evaluation of drugs that prevent or attenuate hyperpulsatility and/or tissue calcification.


Subject(s)
Aorta/pathology , Blood Pressure/physiology , Calcinosis/pathology , Calcinosis/physiopathology , Kidney Failure, Chronic/pathology , Kidney Failure, Chronic/physiopathology , Albuminuria/pathology , Albuminuria/physiopathology , Animals , Animals, Outbred Strains , Atrophy , Body Weight , Calcium/blood , Disease Models, Animal , Fibrosis , Glomerulosclerosis, Focal Segmental/pathology , Glomerulosclerosis, Focal Segmental/physiopathology , Kidney/pathology , Kidney/physiology , Kidney Glomerulus/pathology , Kidney Glomerulus/physiopathology , Male , Rats , Rats, Wistar
9.
Am J Physiol Regul Integr Comp Physiol ; 289(4): R1137-43, 2005 Oct.
Article in English | MEDLINE | ID: mdl-15919735

ABSTRACT

Reversal by the mineralocorticoid receptor antagonist spironolactone on cardiac and renal abnormalities, associated with long-term (since weaning) administration of a high (2 and 8% NaCl chow, HS2 and HS8) sodium diet, was assessed in Sprague-Dawley rats. At the age of 5 mo, spironolactone (20 or 100 mg/kg, gavage) or placebo were given for 14 days to HS2 and HS8 rats. A group fed a regular diet (0.8% NaCl, NS) remained untreated. High sodium intake had no detectable effect on blood pressure; however, cardiac mass index and cross-sectional area of the carotid artery, as well as albuminuria, were increased only in the HS8 group compared with the control group on NS diet. In addition, a marked reduction in glomerular filtration rate (by 40%), associated with a nonproportional fall in renal plasma flow (thus resulting in a decrease in filtration fraction), was observed only in the HS8 group. No change in cardiac and renal fibrosis was detected. Production of the reactive oxygen species (ROS) by aortic tissue was increased in HS8 rats, whereas ROS production by the heart was unaffected. Only the high dose of spironolactone was effective, as it markedly reversed the cardiac hypertrophy and renal hypofiltration associated with the HS8 feeding. The changes were observed in the absence of any effect on systemic blood pressure and production of ROS. These observations favor aldosterone's role in the deleterious effects of marked and prolonged increases in sodium intake.


Subject(s)
Cardiomegaly/chemically induced , Cardiomegaly/prevention & control , Kidney Diseases/chemically induced , Kidney Diseases/prevention & control , Sodium, Dietary/adverse effects , Sodium/administration & dosage , Sodium/adverse effects , Spironolactone/administration & dosage , Administration, Oral , Animals , Blood Pressure/drug effects , Body Weight/drug effects , Cardiomegaly/pathology , Cardiomegaly/physiopathology , Diuretics/administration & dosage , Drug Interactions , Heart Rate/drug effects , Kidney Diseases/pathology , Kidney Diseases/physiopathology , Male , Organ Size/drug effects , Rats , Rats, Sprague-Dawley
10.
Hypertension ; 46(2): 372-9, 2005 Aug.
Article in English | MEDLINE | ID: mdl-15967870

ABSTRACT

Specific treatment of age-related aortic wall arteriosclerosis and stiffening is lacking. Because ligands for peroxisome proliferator-activated receptor gamma have beneficial effects on the arterial wall in atherosclerosis, via an antiinflammatory mechanism, we investigated whether long-term pioglitazone (Pio) treatment protects against another form of vascular wall disease, arteriosclerosis. We evaluated, in a rat model of elastocalcinotic arteriosclerosis (hypervitaminosis D and nicotine [VDN]), whether Pio (3 mg . kg(-1) per day for 1.5 month PO) attenuated arteriosclerosis and its consequences: aortic wall rigidity, increased aortic pulse pressure, and left ventricular hypertrophy. In VDN rats, medial calcification was associated with monocyte/macrophage infiltration and induction of tumor necrosis factor alpha and interleukin 1beta. Pio increased nuclear peroxisome proliferator-activated receptor gamma immunostaining in the aortic wall, decreased tumor necrosis factor alpha (P <0.05 versus VDN Pio-), tended to decrease interleukin 1beta mRNA expression (P =0.08 versus VDN Pio-), blunted aortic wall calcification (271+/-69, P <0.05 versus VDN Pio- 562+/-87 micromol . g(-1) dry weight) and prevented fragmentation of elastic fibers (segments per 10,000 microm2: 8.4+/-0.3; P <0.05 versus VDN Pio- 10.5+/-0.6). Pio reduced aortic wall stiffness (elastic modulus/wall stress: 4.8+/-0.6; P <0.05 versus VDN Pio- 10.0+/-1.6), aortic pulse pressure (30+/-2 mm Hg; P <0.05 versus VDN Pio- 39+/-4) and left ventricular hypertrophy (1.58+/-0.05 g . kg(-1); P <0.05 versus VDN Pio- 1.76+/-0.06). In conclusion, long-term Pio treatment attenuates aortic wall elastocalcinosis and, thus, lowers aortic wall stiffness, aortic pulse pressure, and left ventricular hypertrophy.


Subject(s)
Aorta/physiopathology , Aortic Diseases/physiopathology , Arteriosclerosis/physiopathology , Calcinosis/physiopathology , Elastic Tissue/physiopathology , Thiazolidinediones/pharmacology , Animals , Aorta/pathology , Aorta, Thoracic/metabolism , Aorta, Thoracic/pathology , Aortic Diseases/pathology , Arteriosclerosis/pathology , Blood Pressure/drug effects , Calcinosis/pathology , Cytokines/metabolism , Elastic Tissue/pathology , Elasticity , Hypertrophy, Left Ventricular/pathology , Macrophages/pathology , Male , Monocytes/pathology , Myocardium/pathology , Organ Size/drug effects , PPAR gamma/metabolism , Pioglitazone , Rats , Rats, Wistar
11.
Kidney Int ; 67(1): 227-36, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15610246

ABSTRACT

BACKGROUND: Nitric oxide is an important vasodilator released from endothelial cells by the calcium-dependent endothelial nitric oxide synthase (NOS). We considered it important to investigate how shear stress/perfusion pressure influenced endothelial cell calcium concentration, nitric oxide release, and autoregulation of the afferent arteriole, since this arteriole controls glomerular filtration rate (GFR) and renin release. METHODS: We used an isolated perfused juxtamedullary nephron preparation and measured calcium with Fura 2, nitric oxide with 4-amino-5 methylamino-2', 7'-difluorescein (DAF-FM) and diameter with an imaging system. A mathematical model was applied to calculate changes in nitric oxide concentration and shear stress/wall tension during perfusion with and without erythrocytes at perfusion pressures varying from 50 to 150 mm Hg. RESULT: Cell-free perfusion increased nitric oxide concentration and abolished autoregulation; addition of erythrocytes or l-arginine analog N-nitro-l-arginine methyl ester (L-NAME) decreased nitric oxide concentration and reinstated autoregulation. Elevated perfusion pressure/elevated shear stress increased nitric oxide release and surprisingly decreased the endothelial cell calcium concentration, with perfusion pressure increase from 50 to 150 mm Hg, using blood perfusion endothelial calcium concentration decreased from 186 +/- 39 to 76 +/- 25 nmol/L and with cell-free perfusion from 116 +/- 33 to 56 +/- 21 nmol/L. CONCLUSION: Nitric oxide scavenging by erythrocytes has a high impact on arteriolar nitric oxide concentration and autoregulatory response. Nitric oxide measurements in endothelial cells of the afferent arteriole showed that increased perfusion pressure/shear stress increased nitric oxide release, while simultaneously endothelial cell calcium concentration decreased, possibly indicating a feedback control of this calcium by nitric oxide release.


Subject(s)
Calcium/metabolism , Nephrons/metabolism , Nitric Oxide/biosynthesis , Animals , Arterioles/anatomy & histology , Arterioles/physiology , Endothelial Cells/metabolism , Endothelium, Vascular/cytology , Endothelium, Vascular/metabolism , Erythrocytes/metabolism , Feedback , Homeostasis , In Vitro Techniques , Male , Models, Biological , Nephrons/blood supply , Nephrons/cytology , Perfusion , Pressure , Rats , Rats, Sprague-Dawley , Stress, Mechanical
12.
J Am Soc Nephrol ; 13(1): 1-9, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11752015

ABSTRACT

Intrarenal distribution and function(s) of the peripheral benzodiazepine receptor (PBR) remain uncertain. The goals of this study were to (1) develop a specific anti-rat PBR antibody and (2) map intrarenal immunoreactive PBR (irPBR) in untreated rats and in rats that received chronic angiotensin II infusion (200 ng/kg per min, subcutaneously, 17 d). A polyclonal rabbit antibody was raised against the C-terminal end of rat PBR (aa 159 to 169). The antibody specifically recognized a single 18-kD protein in whole kidney extracts, and confocal microscopy showed exclusive mitochondrial localization of irPBR in cultured rat glial C6 cells. In control rats, irPBR was found along thick ascending limbs of Henle's loops, including the macula densa area, along distal tubules, and along collecting ducts. Vascular smooth-muscle cells were PBR-positive. General irPBR distribution was unaffected by angiotensin II treatment (systolic BP, 205 +/- 9 mmHg). However, irPBR appeared in parietal glomerular epithelial cells, atrophic proximal tubules, and infiltrating mononuclear cells. In conclusion, the results suggest previously unsuspected roles of PBR in the control of glomerular dynamics and in proximal tubular injury/repair processes.


Subject(s)
Angiotensin II , Hypertension/chemically induced , Hypertension/metabolism , Kidney/metabolism , Receptors, GABA-A/metabolism , Angiotensin II/pharmacology , Animals , Blood Pressure/drug effects , Body Weight/drug effects , Hypertension/pathology , Hypertension/physiopathology , Immunohistochemistry , Male , Rats , Rats, Sprague-Dawley , Reference Values , Serum Albumin/analysis , Tissue Distribution
13.
J Renin Angiotensin Aldosterone Syst ; 2(1_suppl): S84-S90, 2001 Mar.
Article in English | MEDLINE | ID: mdl-28095223

ABSTRACT

Our goal was to assess the cardiovascular and renal protection afforded by angiotensin II type 1-receptor blockade against NG-nitro-L-arginine methyl ester (L-NAME)-exacerbated hypertension in young spontaneously hypertensive rats (SHR), in comparison with the antihypertensive drug, hydralazine. Male SHR were assigned to four groups (n=8 per group): no treatment (controls); L-NAME-treated group (20 mg/kg/day, 10 days, orally); co-treatment with L-NAME and hydralazine (15 mg/kg/day, by gavage); co-treatment with L-NAME and candesartan cilexetil (10 mg/kg/day, by gavage), i.e. at a dose that inhibited acute pressor responses to 5-20 ng angiotensin II. One animal died in the L-NAME group, and tail-cuff systolic blood pressure (SBP) increased significantly compared with controls to 201±5 mmHg. Albumin excretion increased 235-fold in L-NAME-treated rats. Heart weight index averaged 3.5±0.1 and 3.8±0.1 mg/g body weight (p<0.05) in control and L-NAME rats, respectively, indicating moderate cardiac hypertrophy induced by L-NAME. Preglomerular vascular lesions affected 63±6% of interlobular arteries and 10±2% of afferent arterioles (vs. 8±3 and 0.8±0.4% in controls, respectively). Hydralazine and candesartan cilexetil treatment similarly reduced SBP to 153±7, and 165±6 mmHg, respectively. However, candesartan provided more protection, in terms of no significant change in albuminuria (vs. 25-fold increase with hydralazine), regression of cardiac hypertrophy, frequency of vascular lesions and histological indices of renal injury maintained within control values. In conclusion, candesartan cilexetil prevented L-NAME-exacerbated hypertension and associated cardio-renal injury in young SHR, the beneficial effects exceeding those of hydralazine.

SELECTION OF CITATIONS
SEARCH DETAIL